Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Not applicableLooking for participantsNCT05439226
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableUnknownNCT02498990
What this trial is testing

Low Calorie Diet and Diabetes

Who this might be right for
Diabetes Mellitus Type 2DyslipidemiaNon-alcoholic Fatty Liver Disease+1 more
Karolinska University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01237119
What this trial is testing

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
University of Birmingham 52
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Large-scale testing (Phase 3)Study completedNCT02929901
What this trial is testing

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Nonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 200
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07020377
What this trial is testing

Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).

Who this might be right for
Diabetes MellitusNon Alcholic Fatty Liver Disease
Amira Bisher,PhD 60
Post-approval studies (Phase 4)Study completedNCT04639414
What this trial is testing

Combined Active Treatment in Type 2 Diabetes With NASH

Who this might be right for
Type 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)
German Diabetes Center 192
Post-approval studies (Phase 4)Study completedNCT02637973
What this trial is testing

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
The Deutsche Diabetes Forschungsgesellschaft e.V. 84
Post-approval studies (Phase 4)UnknownNCT03648554
What this trial is testing

Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Central Hospital, Nancy, France 93
Testing effectiveness (Phase 2)Study completedNCT02330549
What this trial is testing

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD

Who this might be right for
Prediabetic StateNon-alcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
Tobira Therapeutics, Inc. 45
Not applicableStudy completedNCT03826381
What this trial is testing

NAFLD Among Patients With Type 2 Diabetes and CKD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney DiseasesType2 Diabetes
Rigshospitalet, Denmark 100
Not applicableLooking for participantsNCT06701968
What this trial is testing

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisMyocardial Infarction+3 more
Uppsala University 150
Not applicableUnknownNCT06098417
What this trial is testing

Biomarkers in the Diagnosis and Prognosis of NAFLD

Who this might be right for
NAFLDObesityLiver Fibrosis+1 more
University of Trieste 500
Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Testing effectiveness (Phase 2)Looking for participantsNCT04501406
What this trial is testing

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida 166
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Post-approval studies (Phase 4)Study completedNCT02649465
What this trial is testing

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Kanazawa University 40
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Not applicableUnknownNCT02459496
What this trial is testing

Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus

Who this might be right for
Type 2 DiabetesNAFLDObesity+2 more
German Institute of Human Nutrition 200
Next Page